Sign in

You're signed outSign in or to get full access.

Nea Management Company, LLC

CIK:0001512848
Venture Capital
$28B AUM
32 holdings
Timonium, MD, United States
Founded:1977
112 employees
Latest filing:Jun 30, 2025

NEA Management Company, LLC is the registered investment adviser affiliate of New Enterprise Associates (NEA), headquartered in Timonium, Maryland, USA. Founded in 1977, NEA is one of the world’s largest venture capital firms, employing over 110 people. The firm primarily serves institutional investors, entrepreneurs, and high-growth technology and healthcare companies, focusing on early, growth, and late-stage investments globally.

Investment Strategy

NEA Management Company, LLC focuses on venture capital investments across technology and healthcare sectors, engaging in funding early-stage startups as well as growth and late-stage businesses. The firm’s approach emphasizes long-term partnerships with entrepreneurs, providing capital, operational expertise, and a broad network to facilitate growth and innovation. NEA’s investment philosophy centers on diversification and value-add support, targeting transformative opportunities with scalability and disruptive potential.

Latest 13F Filing Activity

Nea Management Company, LLC filed their most recent 13F report on Jun 30, 2025 disclosing 31 equity positions with a total 13F market value of $1B. The fund increased holdings in Verona Pharma PLC, Rhythm Pharmaceuticals Inc., Oric Pharmaceuticals Inc. among other positions. Nea Management Company, LLC reduced exposure to Tempus Ai Inc., CVRX Inc., Savara Inc. among others.

Top Buys
V
VRNAVERONA PHARMA PLC
+$43.4M
R
RYTMRHYTHM PHARMACEUTICALS INC
+$29.7M
O
ORICORIC PHARMACEUTICALS INC
+$29.6M
C
COURCOURSERA INC
+$27.0M
C
CRSPCRISPR THERAPEUTICS AG
+$23.2M
Top Sells
T
TEMTEMPUS AI INC
-$126.2M
C
CVRXCVRX INC
-$12.9M
S
SVRASAVARA INC
-$12.0M
R
RGLSREGULUS THERAPEUTICS INC
-$11.3M
D
DMDESKTOP METAL INC
-$7.1M

Top Holdings

A
ACLXARCELLX INC
+18.6%$246.6M
V
VRNAVERONA PHARMA PLC
+16.1%$214.0M
R
RYTMRHYTHM PHARMACEUTICALS INC
+13.8%$183.9M
C
COURCOURSERA INC
+8.5%$112.7M
C
CRSPCRISPR THERAPEUTICS AG
+5.8%$77.2M

Equity Positions (31)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
ARCELLX INC18.56%$246.6M3,745,262$14.21$65.85+$936.3K
VERONA PHARMA PLC16.11%$214.0M2,263,138$8.76$94.58+$43.4M
RHYTHM PHARMACEUTICALS INC13.84%$183.9M2,909,956$29.06$63.19+$29.7M
COURSERA INC8.49%$112.7M12,867,769$45.00$8.76+$27.0M
CRISPR THERAPEUTICS AG5.81%$77.2M1,587,854$22.19$48.64+$23.2M

Industry Allocation

PHARMACEUTICAL PREPARATIONS
+60.7%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+22.2%
SERVICES-PREPACKAGED SOFTWARE
+8.3%
SERVICES-MEDICAL LABORATORIES
+5.8%
HOSPITAL & MEDICAL SERVICE PLANS
+1.0%

Investment Team (41)

NameRoleLocationLinkedIn
Alex Sharata
Alex Sharata
PartnerMiami, FL , United States
Ann Bordetsky
Ann Bordetsky
PartnerCA , United States
Arjun Jain
Arjun Jain
PrincipalNew York, NY , United States
Ed Mathers
Ed Mathers
PartnerBethesda, MD , United States
James Buxton
James Buxton
PrincipalNew York, NY , United States
Ken Li
Ken Li
Senior Investment ManagerMenlo Park, CA , United States
Mustafa Neemuchwala
Mustafa Neemuchwala
PartnerNew York, NY , United States
Patrick Kerins
Patrick Kerins
General PartnerJupiter, FL , United States
Scott Sandell
Scott Sandell
Chairman, CEO and Chief Investment OfficerUnited States
Ali Behbahani
Ali Behbahani
PartnerPhiladelphia, PA , United States
Showing 1-10 of 41 team members